These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34189794)

  • 1. Chemical and microbiological stability of diluted ceftazidime in three different solutions under three storage temperatures over a 28 day period.
    Hoff SE; Berger DJ; Viall AK; Schrunk D; Noxon JO
    Vet Dermatol; 2021 Oct; 32(5):456-e124. PubMed ID: 34189794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
    Karampatakis V; Papanikolaou T; Giannousis M; Goulas A; Mandraveli K; Kilmpasani M; Alexiou-Daniel S; Mirtsou-Fidani V
    Acta Ophthalmol; 2009 Aug; 87(5):555-8. PubMed ID: 18700884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of ceftazidime-avibactam combined with colistin against extensively drug-resistant Pseudomonas aeruginosa].
    Mei Q; Geng S; Fang X; He Y; Liu L; Xu M; Zhu C; Pan A
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Oct; 31(10):1212-1218. PubMed ID: 31771717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
    Roudashti S; Zeighami H; Mirshahabi H; Bahari S; Soltani A; Haghi F
    World J Microbiol Biotechnol; 2017 Mar; 33(3):50. PubMed ID: 28188589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.
    Otani S; Hiramatsu K; Hashinaga K; Komiya K; Umeki K; Kishi K; Kadota JI
    J Infect Chemother; 2018 Jun; 24(6):428-433. PubMed ID: 29449129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ceftazidime degradation in glass bottles and plastic bags under various conditions.
    Arsène M; Favetta P; Favier B; Bureau J
    J Clin Pharm Ther; 2002 Jun; 27(3):205-9. PubMed ID: 12081634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa.
    Corbella L; Boán J; San-Juan R; Fernández-Ruiz M; Carretero O; Lora D; Hernández-Jiménez P; Ruiz-Ruigómez M; Rodríguez-Goncer I; Silva JT; López-Medrano F; Lizasoain M; Villa J; Caro-Teller JM; Aguado JM
    Int J Antimicrob Agents; 2022 Feb; 59(2):106517. PubMed ID: 34990760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of tobramycin and ceftazidime in icodextrin peritoneal dialysis solution.
    Pallotta KE; Elwell RJ; Nornoo AO; Manley HJ
    Perit Dial Int; 2009; 29(1):52-7. PubMed ID: 19164253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of enrofloxacin stability and in vitro efficacy against Staphylococcus pseudintermedius and Pseudomonas aeruginosa in four ear cleaner solutions over a 28 day period.
    Metry CA; Maddox CW; Dirikolu L; Johnson YJ; Campbell KL
    Vet Dermatol; 2012 Feb; 23(1):23-8, e6. PubMed ID: 21777310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of dilutions of methadone alone, and in combination with lidocaine and ketamine.
    Gomez A; Al-Tannak N; Auckburally A; Watson D; Flaherty D
    J Small Anim Pract; 2022 Jul; 63(7):526-531. PubMed ID: 35246850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-State Ceftazidime-Avibactam Serum Concentrations and Dosing Recommendations in a Critically Ill Patient Being Treated for Pseudomonas aeruginosa Pneumonia and Undergoing Continuous Venovenous Hemodiafiltration.
    Soukup P; Faust AC; Edpuganti V; Putnam WC; McKinnell JA
    Pharmacotherapy; 2019 Dec; 39(12):1216-1222. PubMed ID: 31596506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa.
    Rodríguez-Núñez O; Ripa M; Morata L; de la Calle C; Cardozo C; Fehér C; Pellicé M; Valcárcel A; Puerta-Alcalde P; Marco F; García-Vidal C; Del Río A; Soriano A; Martínez-Martínez JA
    J Glob Antimicrob Resist; 2018 Dec; 15():136-139. PubMed ID: 30036695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro stability of fortified ophthalmic antibiotics stored at -20 degrees C for 6 months.
    Chédru-Legros V; Fines-Guyon M; Chérel A; Perdriel A; Albessard F; Debruyne D; Mouriaux F
    Cornea; 2010 Jul; 29(7):807-11. PubMed ID: 20489598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of colistin against multidrug-resistant Pseudomonas aeruginosa isolates from patients in Songklanagarind Hospital, Thailand.
    Tunyapanit W; Pruekprasert P; Laoprasopwattana K; Chelae S
    Southeast Asian J Trop Med Public Health; 2013 Mar; 44(2):273-80. PubMed ID: 23691637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).
    Ranganathan D; Naicker S; Wallis SC; Lipman J; Ratanjee SK; Roberts JA
    Perit Dial Int; 2016; 36(4):421-6. PubMed ID: 26493753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological efficacy and stability of diluted ticarcillin-clavulanic acid in the topical treatment of Pseudomonas aeruginosa infections.
    Bateman FL; Moss SM; Trott DJ; Shipstone MA
    Vet Dermatol; 2012 Apr; 23(2):97-102, e22. PubMed ID: 22050006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Synergistic Activity of
    Isaei E; Mansouri S; Rahmani M; Sharififar F; Salary A
    Arch Iran Med; 2021 Sep; 24(9):684-688. PubMed ID: 34816684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation.
    Krapp F; Grant JL; Sutton SH; Ozer EA; Barr VO
    Int J Antimicrob Agents; 2017 Jun; 49(6):770-773. PubMed ID: 28389354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension.
    Lambert O; Bandilla D
    Drug Des Devel Ther; 2012; 6():235-44. PubMed ID: 23049244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of β-Lactamase Content of Ceftazidime-Resistant Pathogens Recovered during the Pathogen-Directed Phase 3 REPRISE Trial for Ceftazidime-Avibactam: Correlation of Efficacy against β-Lactamase Producers.
    Mendes RE; Castanheira M; Woosley LN; Stone GG; Bradford PA; Flamm RK
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.